Mood disorders
-
Professor Bernadka Dubicka – Editor in Chief
Editor in Chief, Bernadka qualified in medicine and psychology at the University of London, completing child psychiatry training and her thesis in adolescent depression at the University of Manchester. She is the chief investigator of the National Institute of Health Research multi-site BAY trial of web-based Behavioural Activation in young people with depression (2022-26).
Read more -
Professor Lina Gega
Lina Gega is Professor of Mental Health at the University of York and Honorary Nurse Consultant at Tees, Esk & Wear Valleys NHS Trust, with a PhD in Health Services Research from the Institute of Psychiatry, King’s College London. She is a Joint Editor of CAMH.
Read more -
Research Review: The internalizing paradox – youth anxiety and depression symptoms, psychotherapy outcomes, and implications for research and practice
Paper from the JCPP – ‘Drawing on recent research, we examine candidate explanations for this paradox to help identify strategies for addressing it by improving outcomes for youth depression.’ John R. Weisz (pic) et al.
Read more -
Development, reach, acceptability and associated clinical changes of a group intervention to improve caregiver-adolescent relationships in the context of adolescent depression
Open Access paper from JCPP Advances – ‘Following a literature search to identify established caregiver interventions, we developed a new group intervention for caregivers through an iterative process including six rounds of the group with caregivers of adolescents age 13–18 in the context of an integrated care pathway for adolescent depression.’ Madison Aitken (pic) et al.
Read more -
Network analysis of ecological momentary assessment identifies frustration as a central node in irritability
Paper from the JCPP – ‘Using a novel network analytic approach with smartphone-based ecological momentary assessment (EMA), we examined how irritability and other anxiety and mood symptoms were connected.’ Wan-Ling Tseng (pic) et al.
Read more -
Family environment and polygenic risk in the bipolar high-risk context
Open Access paper from JCPP Advances – ‘We tested the association of offspring-perceived family environment in interaction with bipolar disorder-polygenic risk on liability for bipolar disorder in offspring at high or low familial risk for bipolar disorder. We used a novel stepwise approach for latent class modeling with predictors and distal outcomes.’ Emma K. Stapp (pic) et al.
Read more -
Association between depression diagnosis and educational attainment trajectories: an historical cohort study using linked data
Open Access paper from the JCPP – To understand the association between clinical depression and course of attainment, we aimed to investigate the attainment trajectories that are generally observed among a community sample of pupils, and test the hypothesis that depression diagnosis is associated with membership of lower or declining attainment trajectories. Alice Wickersham (pic) et al.
Read more -
Review: Digital experiences and their impact on the lives of adolescents with pre-existing anxiety, depression, eating and nonsuicidal self-injury conditions – a systematic review
Open Access paper from the CAMH journal 2023 Special Issue – “We review publications relating to anxiety, depression, eating disorders and nonsuicidal self-injury to identify common and condition-specific digital experiences and how these may be implicated in the origins and maintenance of these mental health conditions”. Katarzyna Kostyrka-Allchorne (pic) et al.
Read more -
Prospective prediction of developing internalizing disorders in ADHD
Open Access paper from the JCPP – “Clinical course in attention-deficit/hyperactivity disorder (ADHD) is highly heterogeneous with respect to both core symptoms and associated features and impairment”. Sarah L. Karalunas (pic) et al.
Read more -
Antidepressants for children and teenagers: what works?
Prescriptions for teenagers are rising. Research has found that the number of 12 to 17 year olds prescribed antidepressants more than doubled between 2005 and 2017. More recent information suggests that prescriptions have continued to increase, especially during the pandemic.
Read more